ABSTRACT
INTRODUCTION
In vitro data suggest that cocoa and chocolate might protect the vascular endothelium by improving nitric oxide (NO) availability (1) . It was recently shown in 2 different studies in healthy volunteers (2, 3) that the cocoa-related increase in NO availability is due to flavanols, ie, a subclass of flavonoids mainly represented by epicatechin and catechin and their oligomers (procyanidins) (4) . In keeping with this, polyphenol-rich dark chocolate but not polyphenol-free white chocolate bars significantly reduced blood pressure in elderly patients with isolated systolic hypertension (5) . Because insulin-mediated increases in NO availability significantly improve insulin-mediated glucose uptake in healthy persons (6, 7) , we hypothesized that polyphenolrich dark chocolate was able to improve insulin sensitivity and decrease blood pressure in healthy subjects. Therefore, we compared the effects of 2 different kinds of chocolate bars, ie, either with a high or a low polyphenol content, on the glucose and insulin responses to an oral glucose challenge and on blood pressure in relatively young subjects without metabolic diseases and cardiovascular disease risk factors.
SUBJECTS AND METHODS

Study population
The study was conducted in 15 healthy persons (7 men and 8 women) aged 33.9 Ȁ 7.6 y (x Ȁ SD) recruited from our medical staff. The study was conducted according to the World Medical Association's Declaration of Helsinki (revised in Edinburgh, October 2000).
Experimental protocol
According to the protocol described by Taubert et al (5) , after a cocoa-free run-in phase of 7 d, participants were randomly assigned to receive either 100 g dark chocolate bars containing Ȃ500 mg polyphenols (5) and providing 480 kcal of energy (Ritter Sport Halbbitter, Alfred Ritter GmbH & Co, Waldenbuch, Germany) or 90 g white chocolate bars over 15 d. The white chocolate bars (90 g) also provided 480 kcal and contained amounts of cocoa butter, macronutrients, fiber, electrolytes, and vitamins similar to those in the dark chocolate bars (5) . At variance with the dark chocolate bars, the white chocolate bars contained skim milk powder, lactose, and butyric fat (Milka; Kraft Foods, Milan, Italy). In addition, no polyphenols are expected to be found in white chocolate (5) . At the end of the above period, the subjects entered a further cocoa-free washout phase of 7 d duration and then were crossed over to the other condition. During the cocoa-free periods, the participants were asked to substitute the chocolate bars for foods of similar energy and macronutrient composition. The diet during the study period was assessed by a diary of daily food intake and by measurement of body weight in accordance with Taubert et al (5) . In particular, a tailored isocaloric diet equal in total energy, energy density, dietary fiber, and macronutrient composition and providing Ȃ1400 kcal/d, excluding the calories derived from chocolate, was given to each study participant at the beginning of the study. The subjects were carefully instructed to maintain their diet and to refrain from flavonoid-rich foods and beverages, including wine and other alcoholic beverages. In all cases, a list of these foods and beverages was given to all healthy subjects.
Each participant, after the first cocoa-free phase of 7 d and then after every 15-d cocoa phase, underwent an oral-glucosetolerance test (OGTT) (75 g D-glucose) (8) after an overnight fast and ͧ12 h from the last chocolate ingestion. Blood glucose and insulin were assessed at time 0 and then 30, 60, 90, 120, and 180 min after the glucose load. OGTT values were used for the homeostasis model assessment of insulin resistance (HOMA-IR) (9-11), the quantitative insulin sensitivity check index (QUICKI) (9) , and the insulin sensitivity index (ISI) described by Matsuda and DeFronzo (12) , ie, 3 well-accepted indexes of insulin resistance (HOMA-IR) and insulin sensitivity (QUICKI and ISI) (9) (10) (11) (12) .
A routine hematochemical check-including serum electrolyte, total cholesterol, HDL-cholesterol, LDL-cholesterol, and triacylglycerols concentrations-was also performed before and after each of the above periods. In addition, blood pressure values and heart rate were also measured daily by a standard mercury sphygmomanometer and a stethoscope. In particular, blood pressure was measured in the Oupatient Unit of our University Department, always by the same physician, who was unaware of the study design, results, and purpose. On each occasion, blood pressure and heart rate were measured in a comfortable room, after the subjects had sat in a sitting position for 10 min, 4 times at 3-min intervals. The first measurement was discarded, and the average of the last 3 blood pressure and heart rate measurements was recorded.
Statistical analysis
Continuous normally distributed data are expressed as means Ȁ SDs. Within each treatment group (ie, either dark or white chocolate), changes in blood pressure and metabolic indexes from baseline values were analyzed by paired Student's t test. For multiple comparisons, data were analyzed with a two-factor repeated-measures analysis of variance (ANOVA) with time and treatment as the 2 factors. Post hoc comparisons were performed by Tukey's honestly significant difference test. Statistical analysis and power calculation were performed with a personal computer and with SAS statistical software (version 8.12, 2000; SAS Institute Inc, Cary, NC).
RESULTS
Baseline characteristics of the study population are shown in Table 1 . As expected, serum lipid, glucose, and insulin concentrations were in the range of normality. Similarly, mean basal values of HOMA-IR, QUICKI, and ISI were also within the range of normality; HOMA-IR was 2.77, QUICKI was 0.331, and ISI was 3.11 (9) (10) (11) (12) . In keeping with this finding, no subject manifested with either impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes.
HOMA-IR was significantly lower after 15 d of dark chocolate ingestion than after 15 d of white chocolate ingestion (Figure 1,  A and B) . QUICKI was significantly higher after 15 d of dark chocolate ingestion than after 15 d of white chocolate ingestion ( Figure 1, C and D) . Moreover, ISI was found to be significantly higher after dark than after white chocolate (15.18 Ȁ 7.69 compared with 7.4 Ȁ 3.5; P ҃ 0.001). Changes in the glucose and insulin responses to the oral glucose challenge further showed the positive effects of dark but not of white chocolate ingestion on glucose metabolism (Figure 2) . In particular, for glucose concentrations, two-factor repeated-measures ANOVA showed a significant effect of both treatment (P 0.0001) and time (P 0.0001) as well as a significant treatment-by-time interaction (P ҃ 0.0039). After ANOVA, the Tukey's honestly significant difference test indicated significant differences between dark chocolate and white chocolate or baseline values at 0, 30, 60, 90, and 120 min (Figure 2) . With regard to insulin concentrations, ANOVA again indicated a significant effect of treatment (P 0.0001) and time (P 0.0001) as well as a significant treatmentby-time interaction (P ҃ 0.0191). After ANOVA, the Tukey's honestly significant difference test indicated significant differences between dark chocolate and white chocolate or baseline values at 0, 30, 60, 90, 120, and 180 min (Figure 2) .
Although within normal values (13), blood pressure showed a trend to be lower after 15 d of dark chocolate than after 15 d of white chocolate ingestion (Figure 3) . However, only difference in systolic blood pressure after either dark or white chocolate were statistically significant (107.5 Ȁ 8.6 compared with 113.9 Ȁ 8.4 m Hg, respectively; P 0.05). There were no influences of sex on the effects of chocolate on HOMA-IR, QUICKI, ISI, or blood pressure. No significant changes in the lipid profile were observed during the entire study period (Table 1) .
DISCUSSION
Cocoa has been claimed to protect the vascular endothelium by augmenting NO availability and thereby improving endothelium-dependent vasorelaxation (1-4) . The current study expands on the above findings, showing that cocoa ingestion not only decreased blood pressure but also improved insulin sensitivity in healthy persons. Thus, although our study was not designed to provide insight about the mechanisms responsible for the observed effects, our study is the first one to show that cocoa may have favorable metabolic effects and thereby further protect against cardiovascular diseases.
The first suggestion of the possible benefits of cocoa came from epidemiologic studies conducted in Kuna Indians, an Amerind population living in the San Blas Island chain off the Coast of Panama that is known to have an extremely low prevalence of atherosclerotic disease, hypertension, diabetes, and dyslipidemia (14, 15) . The low cardiovascular mortality observed in Kuna Indians has been hypothesized to be consequent to high ingestion of cocoa-rich beverages (14, 15) . In keeping with this, recent studies showed that flavanols, a subclass of flavonoids that is richly represented in natural cocoa beans, increase NO production by cultured human vascular endothelial cells (16) and improve endothelium-dependent vasorelaxation (NO-dependent) in finger (2) and brachial (3) arteries of healthy humans. Because insulin sensitivity is, at least in part, dependent on NO availability, ie, on insulin-stimulated NO production (6, 7), we hypothesized that dark chocolate containing polyphenols might improve insulin sensitivity in vivo. We showed that dark chocolate but not white chocolate bars decreased fasting insulin and glucose concentrations as well as the glucose and insulin responses to the oral glucose challenge. As a direct consequence of these changes, we also showed that dark chocolate bars simultaneously decreased the well-recognized marker of insulin resistance, HOMA-IR, and increased 2 distinct indexes of insulin sensitivity, ie, the QUICKI and the ISI.
With regard to possible study limitations, we cannot state that positive changes in insulin sensitivity induced by dark chocolate bars were due to increased NO availability. Nevertheless, the decrease in blood pressure observed after ingestion of dark chocolate bars supports this hypothesis. On the other hand, although FIGURE 1. Effects of either dark (A and C) or white (B and D) chocolate on the homeostasis model assessment of insulin resistance (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI) in 15 healthy subjects. No significant differences were found between the "before" values (baseline), which indicated the absence of a carryover effect. In contrast, HOMA-IR was significantly lower (P 0.001, paired t test) and QUICKI was significantly higher (P ҃ 0.001, paired t test) after dark than after white chocolate ingestion, which further confirmed the beneficial effect of dark chocolate on both HOMA-IR and QUICKI. In all panels, the symbols represent means, and the vertical lines represent SDs. * Significantly different from white chocolate and baseline, P 0.05 (Tukey's honestly significant difference test after a two-factor repeatedmeasures ANOVA found an interaction between treatment and time). The baseline data represent the first measurements; the second measurements were omitted for clarity.
other flavanol-related changes, such as those in prostaglandin synthesis and thromboxane production (17) , have all the biological potential to induce significant modifications of insulin sensitivity, the particular study design that we have adopted minimizes study bias due to confounding factors, including type II statistical error and the order effect. Therefore, whatever the mechanism underlying the observed positive effects exerted by dark chocolate bars on insulin sensitivity, our data are consistent with the fact that increased insulin sensitivity represents a novel potential benefit derived from cocoa. Although we cannot completely exclude the contribution of other substances present in dark but not in white chocolate bars to the positive effects of dark chocolate on insulin sensitivity and blood pressure, it seems extremely likely that flavanols were responsible for the above effects.
In conclusion, the current study showed that polyphenol-rich dark chocolate but not white chocolate (which contains cocoa butter) decreases blood pressure and improves insulin sensitivity in healthy persons. These findings indicate that dark chocolate may exert a protective action on the vascular endothelium also by improving insulin sensitivity. Obviously, large scale trials are needed to confirm these protective actions of dark chocolate or other flavanol-containing foods in populations affected by insulin-resistant conditions such as essential hypertension and obesity. In the meantime, we conclude that our findings further contribute to explain the reasons why, in his Systema Naturae (1735), Carl von Linnè first classified the cocoa tree as Theobroma Cacao, ie, "the divine food" (18) .
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